Improving Tobacco Cessation: CMS Guidance and State Strategies
Lisa Kroon, PharmD, CDCES, FAPhA
Dr. Lisa Kroon is a Professor of Clinical Pharmacy in the Department of Clinical Pharmacy at the School of Pharmacy at the University of California in San Francisco. She is also the Assistant Chief Pharmacy Office of Clinical Innovation, Education and Research at UCSF Health and oversees ambulatory pharmacy practice. Dr. Kroon received her Doctor of Pharmacy at the University of Michigan and then completed two years of residency at UCSF in pharmacy practice and hospital pharmacy administration. She has been a member of the UCSF faculty since 1996. She practices at the UCSF Health Diabetes Teaching Center, where she cares for people with diabetes. Dr. Kroon is the Co-Director of the UCSF Health Fontana Tobacco Treatment Center where she has been a smoking cessation provider for over 20 years. Her current research interests include evaluating the impact of pharmacist provider status and expanded scope of practice, diabetes therapeutics, tobacco cessation, and innovative pharmacy practice models.
Deirdra Stockmann, Ph.D., M.U.P. is the Director of the Division of Quality and Health Outcomes in the Center for Medicaid and CHIP Services at the Centers for Medicare & Medicaid Services (CMS). Since joining CMS in 2012, Deirdra has worked with state Medicaid and CHIP agencies and their partners to improve health outcomes by improving access to and quality of health services for people enrolled in Medicaid and CHIP. Before joining CMS, Deirdra worked on multi-stakeholder collaborations to address social determinants of health and other aspects of community wellbeing. Deirdra holds a Ph.D. and Masters in Urban Planning from the University of Michigan and a Bachelors from the University of Pennsylvania.
Ivana Thompson earned her Pharm.D. degree from University of the Pacific School of Pharmacy and has been practicing in California for over 20 years. She has worked in community and outpatient pharmacies, then as a consultant pharmacist for Medi-Cal DUR. Ivana took a leadership position managing Medicaid pharmacy operations with PBM overseeing 24+ Medicaid Managed Care plans from 20+ states. She is currently the Chief of pharmacy Clinical Operations Section, at California Department of Healthcare Services, where she oversees Medi-Cal Rx, a statewide Medicaid pharmacy benefit, and is responsible for Medi-Cal DUR Program.
- Describe how state Medicaid and CHIP agencies are working with health departments and health plans to improve delivery of tobacco cessation services to Medicaid and CHIP beneficiaries.
- Describe two pharmacist care models for smoking cessation in California.
- List the smoking cessation medications that pharmacists are able to furnish in California.
- Explain the power of how contracting with Medicaid or Medicaid MCOs can improve the delivery of tobacco treatment in health and behavioral healthcare settings
- Describe critical contracting elements to ensure successful implementation of tobacco treatment integration.